Market Overview

The Global Autologous Matrix-induced Chondrogenesis Market was valued at USD 193.5 million in 2023 and is expected to reach USD 374.4 million by 2031 while growing at a CAGR of 8.6% during the forecast period (2024-2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global autologous matrix-induced chondrogenesis market growth. AMIC, a surgical technique for treating cartilage defects in joints, especially the knee, involves stimulating damaged cartilage regeneration. It combines microfracture surgery with the application of a biological scaffold or matrix.

The rising prevalence of joint disorders and continuous progress in regenerative medicine and tissue engineering is anticipated to fuel substantial growth in the autologous matrix-induced chondrogenesis market. However, challenges like high treatment costs and regulatory approvals, along with compliance issues with healthcare standards, could impede market expansion.

Furthermore, the global autologous matrix-induced chondrogenesis industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Material Analysis

The Global Autologous Matrix-induced Chondrogenesis Market is segmented among Hyaluronic Acid, Collagen, Polyethylene Glycol (PEG), Poly Lactic-co-glycolic Acid (PLGA), and Other Materials, based on Material. In 2023, Collagen accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Application Analysis

The Global Autologous Matrix-induced Chondrogenesis Market is segmented among Knee Cartilage, Elbow Cartilage, and Other Applications, based on Application. In 2023, Knee Cartilage accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Autologous Matrix-induced Chondrogenesis Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Anika Therapeutics, Inc., Arthro-Kinetics, B. Braun SE, CartiHeal, Geistlich Group (Geistlich Pharma AG), JRI Orthopaedics, Matricel GmbH, Smith+Nephew, Zimmer Biomet Holdings, and CONMED Corporation.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Autologous Matrix-induced Chondrogenesis Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Autologous Matrix-induced Chondrogenesis Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Autologous Matrix-induced Chondrogenesis Market Segmentation, By Material

• Global Autologous Matrix-induced Chondrogenesis Market Share Analysis, By Material

• Global Autologous Matrix-induced Chondrogenesis Market Growth Analysis, By Material

• Global Autologous Matrix-induced Chondrogenesis Market Trends, By Material

o Hyaluronic Acid

o Collagen

o Polyethylene Glycol (PEG)

o Poly Lactic-co-glycolic Acid (PLGA)

o Other Materials

6. Global Autologous Matrix-induced Chondrogenesis Market Segmentation, By Application

• Global Autologous Matrix-induced Chondrogenesis Market Share Analysis, By Application

• Global Autologous Matrix-induced Chondrogenesis Market Growth Analysis, By Application

• Global Autologous Matrix-induced Chondrogenesis Market Trends, By Application

o Knee Cartilage

o Elbow Cartilage

o Other Applications

7. Global Autologous Matrix-induced Chondrogenesis Market Segmentation, By Region

• Global Autologous Matrix-induced Chondrogenesis Market Share Analysis, By Region

• Global Autologous Matrix-induced Chondrogenesis Market Growth Analysis, By Region

• Global Autologous Matrix-induced Chondrogenesis Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Anika Therapeutics, Inc.*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Arthro-Kinetics

• B. Braun SE

• CartiHeal

• Geistlich Group (Geistlich Pharma AG)

• JRI Orthopaedics

• Matricel GmbH

• Smith+Nephew

• Zimmer Biomet Holdings

• CONMED Corporation

  *Similar analysis will be provided for each company listed above.